Yuandong Biology: Net profit in 2025 was 283 million yuan, an increase of 18.89% year-on-year.

Yuandong Biotechnology released its performance flash report, achieving total operating revenue of 1.331 billion yuan in 2025, a decrease of 1.36% year-on-year; net profit was 283 million yuan, an increase of 18.89% year-on-year. During the reporting period, affected by the impact of the tenth batch of national centralized drug procurement tender, total operating revenue decreased slightly; the company actively took multiple measures such as optimizing revenue structure, strengthening cost control, and improving operational efficiency to increase technical service and transfer income, reduce costs, and offset the adverse effects of the tenth batch of centralized drug procurement tenders, eventually achieving stable growth in profitability.